Gujarat Terce Laboratories reschedules board meeting to May 29
Gujarat Terce Laboratories Limited has moved its board meeting to 29 May 2026 to approve audited standalone financial results for Q4 and FY26. The meeting was originally set for 27 May 2026.
*this image is generated using AI for illustrative purposes only.
Gujarat Terce Laboratories Limited has rescheduled its board meeting to Friday, 29 May 2026, to consider and approve the audited standalone financial results for the fourth quarter and year ended 31 March 2026. The meeting was originally scheduled for Wednesday, 27 May 2026, but was postponed due to unavoidable circumstances.
The company informed BSE Limited that the rescheduled meeting will be held to review the audited standalone financial results for the period. The intimation was submitted under Regulation 50(1)(c) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
| Event | Original Date | Rescheduled Date |
|---|---|---|
| Board Meeting | 27 May 2026 | 29 May 2026 |
| Purpose | Consideration of audited standalone financial results for Q4 and year ended 31 March 2026 | Consideration of audited standalone financial results for Q4 and year ended 31 March 2026 |
The request to take the rescheduling on record was made by Company Secretary Ashka Solanki. The filing confirmed that the meeting agenda remains focused on the approval of the financial results for the specified period.
Historical Stock Returns for Gujarat Terce Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.26% | +0.20% | -7.89% | -26.08% | -40.55% | +286.33% |
What are the market expectations for Gujarat Terce's Q4 and full-year financial performance?
Could the rescheduling indicate potential complexities in finalizing the audited results?
How might the delayed announcement impact the company's stock volatility in the interim period?
17
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
